Observational Study of NovoNorm® in Subjects With Diabetes
NCT01498913 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5841
Last updated 2017-02-20
Summary
This study is conducted in Asia. The aim of this study is to review the safety and efficacy of Novonorm® (repaglinide) in post-marketing use.
Conditions
- Diabetes
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
repaglinide
Prescription with NovoNorm® 0.5mg, 1mg or 2mg tablets according to product labelling in daily clinical practice at the discretion of the physician
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-08-30
- Primary Completion
- 2005-03-25
- Completion
- 2005-03-25
Countries
- South Korea
Study Locations
More Related Trials
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects
NCT01597713 ·Status: COMPLETED ·Phase: PHASE1
-
An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment
NCT00698269 ·Status: COMPLETED
-
Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication
NCT00869908 ·Status: COMPLETED
-
A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes
NCT01849289 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes
NCT01536600 ·Status: COMPLETED
-
Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents
NCT00715780 ·Status: COMPLETED
-
NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
NCT01492153 ·Status: COMPLETED
-
Observational Study of Patients With Diabetes Using Levemir® FlexPen®
NCT00670683 ·Status: COMPLETED
-
A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
NCT02911948 ·Status: COMPLETED ·Phase: PHASE3
-
Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients
NCT00941369 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes
NCT01545791 ·Status: COMPLETED
-
Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus
NCT00709475 ·Status: COMPLETED
-
Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes
NCT00700765 ·Status: COMPLETED
-
Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes
NCT01565733 ·Status: COMPLETED
-
Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus
NCT00290979 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba®
NCT01984372 ·Status: COMPLETED
-
A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine
NCT04575181 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes
NCT00698126 ·Status: COMPLETED
-
Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes
NCT00771680 ·Status: COMPLETED
-
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
NCT01952145 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice
NCT01492166 ·Status: COMPLETED
-
Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects
NCT01405261 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Analogues and Severe Hypoglycaemia
NCT00346996 ·Status: COMPLETED ·Phase: PHASE4
-
Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
NCT05689372 ·Status: ENROLLING_BY_INVITATION
-
Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
NCT01288326 ·Status: COMPLETED